ARTICLE | Clinical News
KC706: Phase I data
August 28, 2006 7:00 AM UTC
Data from 3 Phase I trials in a total of 79 health volunteers showed that KC706 was safe and well tolerated and confirmed the bioavailability of the compound in a capsule formulation. ...